• Ivermectin in Parasitology Research: Mechanisms, Integrity,

  2026-06-25

  Explore how Ivermectin, a broad-spectrum anti-parasitic, advances parasitology research with unmatched purity and mechanism-driven efficacy. This article uniquely bridges rigorous compound handling with new findings from oncology, offering researchers a deeper perspective.

• GDC-0068 (RG7440): Selective Pan-AKT Inhibition in PI3K/Akt/

  2026-06-25

  GDC-0068 (RG7440) is a potent, ATP-competitive pan-AKT inhibitor designed for selective targeting of Akt1, Akt2, and Akt3. It is widely used to dissect PI3K/Akt/mTOR pathway dynamics and tumor cell fate. APExBIO's GDC-0068 offers robust selectivity, high solubility in DMSO and ethanol, and validated efficacy in multiple cancer models.

• Patient-Derived 3D Spheroids Advance Prostate Cancer Modelin

  2026-06-24

  This study presents a robust protocol for generating patient-derived three-dimensional (3D) spheroid cultures from radical prostatectomy specimens, providing a physiologically relevant in vitro model for organ-confined prostate cancer. The findings highlight the model's cellular fidelity and its practical utility for drug-response studies, holding promise for more translationally relevant prostate cancer research.

• Metal-Ion Chelating L-Phe Nanostructures Boost ICB in Breast

  2026-06-23

  This study reveals that metal-ion-chelating L-phenylalanine nanostructures, when combined with short-term starvation, can remodel the tumor microenvironment and enhance the efficacy of immune checkpoint blockade in breast cancer. The work elucidates a novel mechanism of dendritic cell activation through ion channel modulation, offering new strategies for overcoming immunotherapy resistance in solid tumors.

• InstaBlue Protein Stain Solution for Rapid Gel Visualization

  2026-06-23

  InstaBlue Protein Stain Solution enables fast, sensitive protein detection in polyacrylamide gels without the need for fixation, washing, or hazardous solvents. It is best used where immediate visualization and downstream mass spectrometry compatibility are required, but may not be appropriate for workflows demanding in-gel renaturation or traditional Coomassie protocols.

• Ranolazine: Protocols and Innovations for Cardiac Ischemia R

  2026-06-22

  Ranolazine stands out as an anti-ischemic agent, shifting cardiac and hepatic metabolism to enhance cellular resilience under ischemic stress. This article delivers protocol enhancements, troubleshooting strategies, and translational insights that empower advanced cardiac ischemia and metabolic research workflows.

• Machine Learning Unlocks Novel Senolytics for Senescence Res

  2026-06-22

  The referenced study demonstrates how machine learning, trained on heterogeneous published data, enabled the identification and validation of new senolytic compounds targeting cellular senescence. This approach offers cost-effective, data-driven strategies for accelerating drug discovery in cancer and aging-related research.

• Moxidectin: Macrocyclic Lactone Anthelmintic for Dual Applic

  2026-06-21

  Moxidectin is a macrocyclic lactone anthelmintic with established efficacy in veterinary parasitic worm control and newly documented synergy with polyene antifungals against Candida albicans. This review details its mechanism, benchmarks, and translational potential, with evidence-backed protocol guidance.

• Merimepodib (VX-497): Expanding Therapeutic Frontiers via Ho

  2026-06-20

  Discover how Merimepodib (VX-497) targets host IMPDH to combat viral infections and modulate immune responses. This deep-dive explores recent breakthroughs, advanced applications, and practical assay insights beyond standard protocols.

• Anti Reverse Cap Analog: Advancing Synthetic mRNA Efficiency

  2026-06-19

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, empowers researchers to maximize mRNA translation and stability in demanding workflows. This article details practical enhancements, troubleshooting, and cutting-edge applications that set ARCA apart for mRNA therapeutics and gene editing.

• Difloxacin HCl in Precision Antimicrobial and MDR Research

  2026-06-19

  Explore how Difloxacin HCl, a quinolone antimicrobial antibiotic, uniquely advances both antimicrobial susceptibility testing and multidrug resistance reversal. This article bridges mechanistic insight with practical assay guidance for innovative research.

• Biotin (Vitamin B7) in Protein Labeling & Metabolic Research

  2026-06-18

  Biotin (Vitamin B7) is not only a metabolic coenzyme but also a cornerstone reagent in high-specificity protein labeling and molecular detection. Discover how APExBIO’s high-purity biotin enables robust experimental workflows, troubleshooting, and innovation across biochemistry and innate immune research.

• JAK Inhibitors Block Sensory Neuron Activation by RA Synovia

  2026-06-18

  This study reveals that Janus kinase inhibitors directly block activation of human sensory neurons induced by rheumatoid arthritis (RA) synovial fluid, offering new mechanistic insight into their superior pain-relief efficacy. The findings clarify how JAK/STAT signaling mediates neuronal sensitization in RA, advancing the understanding of pain management in inflammatory disease.

• nor-Binaltorphimine Dihydrochloride: Redefining Pain Circuit

  2026-06-17

  This article explores how nor-Binaltorphimine dihydrochloride, a highly selective κ-opioid receptor antagonist, enables translational researchers to dissect the central neural circuits underpinning opioid-induced mechanical hypersensitivity and tolerance. Combining mechanistic detail with strategic workflow guidance, it synthesizes cutting-edge findings—including the newly identified lPBNMOR+/PVHDyn+/SDHKOR-GABA axis—and highlights APExBIO’s reagent value for advanced opioid receptor signaling research. The discussion bridges literature-backed protocol advice with a visionary outlook for pain modulation research beyond conventional product pages.

• Tiamulin (Thiamutilin): Optimizing Veterinary and Anti-Infla

  2026-06-17

  Tiamulin (Thiamutilin) offers dual-action efficacy—controlling veterinary infections and modulating TNF-α-mediated inflammation. This article translates recent experimental breakthroughs and protocol refinements into actionable steps for researchers and veterinarians seeking robust, reproducible results.

445 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page